A new case warns that relying on AI for diet advice can be dangerous, as a man replaced salt with sodium bromide and developed life-threatening toxicity
AI tool predicts liver cancer relapse with 82% accuracy, tackling a disease causing third-highest cancer-related deaths globally
With trust in science under scrutiny, a global initiative seeks to catch manipulated or inaccurate medical studies before they influence clinical or policy decisions
AI chatbots often give biased or incomplete health advice when users ask leading or vague questions, warns a new Google-backed study
Various experts in India, too, reiterate the concerns of overdependence on AI, to the extent where people outsource even thinking to AI
Global bio-pharmaceutical company AstraZeneca has established its state-of-the-art Global Hub in Bengaluru investing Rs 166 crore to focus on development of AI-powered healthcare solutions, a top official said on Thursday. This marks the second major investment by AstraZeneca in July 2024 after it announced expansion of its Global Innovation and Technology Centre in Chennai with an outlay of Rs 250 crore. The new facility in Bengaluru is designed to accommodate nearly 1,300 employees including 400 new jobs. It will support the company's capabilities in AI-powered innovation across Research and Development, global business services, Information Technology and digital health operations, among others. The Global Hub in Bengaluru is dedicated to Research and Development, Global Business Services, Information Technology while the Global Innovation and Technology Centre in Chennai serves as a strategic hub for IT, Global Business Services. Following the expansion of the facility, the ...
AI meets leadership in this episode of Manager’s Mantra with Dr. Harsha Gurulingappa, Global Head of AI at Merck. Learn how tech is reshaping healthcare and what it takes to lead in the AI era.
Developed over five years, the AI-powered system uses imaging and microfluidics to detect rare signs of male infertility-ushering in a leap for reproductive medicine
Tencent-backed Synyi AI opens a clinic in Saudi Arabia where patients are diagnosed by AI and treatment plans are reviewed by human doctors for safety
OpenAI's HealthBench benchmark tests how safely and accurately AI like ChatGPT can handle health queries, suggest treatments, and support doctors using physician-designed real-world scenarios
The ILO's 2025 safety report highlights how AI and digitalisation are transforming occupational safety while also warning of new risks from automation and surveillance
DeepSeek is now global force. But it's just one player in China's booming AI industry
Mukesh Ambani said that early detection is half the battle won in the fight against cancer at an event in Bengaluru
Company uses AI to recommend personalised fitness and nutrition plans
Healthtech firm Dozee's AI-powered system alerted patients' health deterioration about 16 hours in advance and continuous monitoring saved 10% of healthcare practitioners' time
In 2023, the world's early AI applications and large language models (LLMs) emerged primarily from the Bay Area, driven by highly specialised PhDs in deep learning. India then lagged in terms of access to these expert resources. A year later, the India story has changed dramatically. The year 2024 will go down as a turning point with engineers in India beginning to develop innovative AI applications across various verticals, without needing deep learning PhDs. The number of AI startups building solutions on top of LLMs has since surged significantly. India is rapidly becoming a global hub for AI applications, says Shekhar Kirani, a partner at global venture capital firm Accel. He points to specific examples that demonstrate India's unique advantage in AI. A Bengaluru-based engineering team, for instance, built an AI application that automates 10-Q filings for US companies. Traditionally handled by accounting firms, the process took several days. However, the team trained a ...
Global venture capital firm Accel on Wednesday announced the launch of Accel Atoms 4.0, the fourth edition of its pre-seed scaling programme, Accel Atoms, that offers chosen startups up to USD 1 million funding along with perks of over USD 5 million from Accel network partners. Accel Atoms 4.0 builds on the success of three previous editions, and is designed to make the journey as frictionless as possible for visionary founders and promising entrepreneurs operating in the two distinct cohorts of AI and Bharat, the VC firm said in a release. Accel Atoms 4.0 is inviting applications from two categories of pre-seed startups - those building for Bharat', and AI (Artificial Intelligence), it said. Applications for the programme open on September 16. Accel defines Bharat' as the middle-income households spread across Tier 2, Tier 3, and rural India. Startups at the pre-seed stage, including idea-stage and pre-product companies, are eligible to apply for this rigorous three-month hybrid .
Revenue rose 125 per cent to a record 16.4 trillion won
Digital innovations are transforming not only clinical applications, but also streamlining administrative processes making the entire health care experience more patient-centric
With the face scan feature, individuals can effortlessly track vital parameters such as blood pressure, pulse rate, heart rate, haemoglobin levels and stress levels